The FDA agreed to review Moderna’s experimental mRNA influenza vaccine after Moderna resubmitted its application with modifications.

As the U.S. backpedals on its mRNA investment, Mexico is embracing the technology through a new manufacturing pact with Moderna to produce vaccines domestically.  | The agreement includes mRNA vaccine ...

The new childhood immunization policies and vaccine schedule from the U.S. Department of Health and Human Services is the ...

In a sudden reversal, the US Food and Drug Administration has agreed to review Moderna’s experimental mRNA influenza vaccine.

The global vaccine Contract Development and Manufacturing Organization (CDMO) market is projected to expand at a compound ...

Union Health Minister JP Nadda on Saturday launched the indigenously manufactured Tetanus and Adult Diphtheria (Td) vaccine ...

Unlike the US, Mexico is bolstering its mRNA offerings with the help of Moderna’s portfolio.

Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This ...

Union Health Minister J P Nadda launched the indigenously manufactured tetanus and adult diphtheria vaccine in Kasauli. The ...

Moderna (MRNA) stock is in focus as the company looks to sign a five year deal to deliver respiratory vaccines to Mexico. Read more here.

A review published in Infection highlights viral mimic systems that safely replicate key features of pathogens like SARS-CoV-2. These technologies allow vaccine testing in lower-level biosafety ...